Guidelines for Management of Atopic Dermatitis — Part IV: Prevention of Disease Flares and Use of Adjunctive Therapies and Approaches

Recommendations to direct AD management and aid patient counseling in the use of valid measures to prevent flares

Sponsoring Organization: American Academy of Dermatology (AAD)

Target Population: Primary care providers, dermatologists, allergists, and pediatricians

Background and Objective

Atopic dermatitis (AD) is a chronic inflammatory skin disease prone to exacerbations and remissions. Comprehensive management requires procedures to prevent disease flares. This fourth and final part of the AAD guidelines for the management of atopic dermatitis addresses currently available evidence on preventing flares. Other parts of the AAD atopic dermatitis guidelines have been reviewed previously (see NEJM JW Dermatol Feb 21 2014 and Jun 11 2014).

Key Points

Topical moisturizers provide skin hydration and some may improve epidermal barrier dysfunction. They have mini…

Reviewing Author

Craig A. Elmets, MD

Disclosures

Consultant / Advisory board Astellas Pharmaceuticals

EquityVaxin

Grant / Research support NIH; NIH/NCI; Veteran’s Administration; Ferndale Laboratories; Kyowa Hakko Kirin Pharma, Inc.

Editorial boards Cancer Prevention Research; Photodermatology, Photoimmunology, & Photomedicine; UpToDate; eMedicine; Journal of Dermatological Sciences; JAMA Dermatology

Leadership positions in professional societies American Academy of Dermatology (Vice Chair, Committee on Science and Research); Photomedicine Society (Board of Directors)